Loading stock data…
$2.17-0.02 (-0.94%)
Beyond Air, Inc.
Beyond Air, Inc. in the Healthcare sector is trading at $2.17 with a market capitalization of $3M. Wall Street consensus targets $20.00 (2 analysts), implying a +821.9% move over the next 12 months. The stock is currently near its 52-week low of $2.11, remaining 81.2% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 25 is oversold, raising the odds of a near-term bounce. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $1.77M↓ | $1.91M↓ | $2.19M↑ | $1.82M↑ | $1.76M |
| Gross Profit | $225,000↑ | $94,000↓ | $300,000↑ | -$298,000↓ | $156,000 |
| Operating Income | -$6.61M↑ | -$7.17M↓ | -$6.60M↑ | -$7.66M↓ | -$7.62M |
| Net Income | -$7.93M↑ | -$10.28M↓ | -$7.34M↑ | -$7.94M↓ | -$7.69M |
Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company. It operates through Beyond Air, Beyond Cancer, and NeuroNos segments. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension o...